Company news
Hitgen Inc. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Indicative Announcement on Postponing Term Change of the Board of Directors and the Board of Supervisors and Proposing Resignation by Independent Director upon Expiration of Term
May 23, 2025
Announcement on Share Increase Plan of Ningbo Juzhi Pioneer Biotechnology Partnership Enterprise (Limited Partnership)
May 22, 2025
2024 Annual Report
April 25, 2025
Indicative Announcement on Planning Major Asset Restructuring and Signing Letter of Intent for Equity Acquisition
March 31, 2025
Announcement on Share Reduction Plan for Shareholders
March 2, 2025
Announcement on Preliminary Earnings Estimate for 2024
February 27, 2025
Announcement on Shareholding Reduction Results for Shareholder Chongqing Boyi Xintian Equity Investment Fund Partnership (L.P.)
February 14, 2025
Announcement on the Result of Shareholding Reduction through Call Auction for Shareholder CS Venture Capital Co., Ltd.
December 27, 2024
Announcement on Shareholding Reduction Plan for Shareholders CS Venture Capital Co., Ltd. and Chongqing Boyi Xintian Equity Investment Fund Partnership (L.P.)
November 19, 2024
Announcement on Convening the Q3 2024 Performance Briefing
October 31, 2024
Report for Q3 2024
October 25, 2024
Announcement on Resolution of the 3rd Extraordinary General Meeting in 2024
September 13, 2024
Announcement on Obtaining Government Grants
September 12, 2024
Announcement on Convening the 2024 Semi-annual Performance Briefing
September 9, 2024
Announcement on Renewing Engagement of Financial Audit Institution and Internal Control Audit Institution for 2024
August 28, 2024
HitGen and Cambridge Molecular announce a strategic partnership, bringing together DNA-Encoded Libraries and Deep Learning
November 4, 2021
Vernalis Research - a Fully Owned Subsidiary of HitGen Inc - and Hannibal Innovation Announce the Creation of Dania Therapeutics ApS
October 31, 2021